Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
Prevail Therapeutics Inc. (PRVL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/26/2021 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,822,463 shares
@ $0 |
|
| 01/26/2021 |
4
| Abeliovich Asa (President & CEO) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 2,385,756 shares
@ $0
Disposed/sold 1,329,219 options to buy
@ $0.18, valued at
$239.3k
Disposed/sold 178,681 options to buy
@ $10.26, valued at
$1.8M
Disposed/sold 250,000 options to buy
@ $16.91, valued at
$4.2M
|
|
| 01/26/2021 |
4
| Adams Timothy M (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 32,400 options to buy
@ $10.26, valued at
$332.4k
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| Carson William H. (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 34,000 options to buy
@ $11.11, valued at
$377.7k
|
|
| 01/26/2021 |
4
| Dai Yong (Chief Technology Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 200,172 options to buy
@ $0.18, valued at
$36k
Disposed/sold 126,567 options to buy
@ $10.26, valued at
$1.3M
Disposed/sold 43,500 options to buy
@ $16.91, valued at
$735.6k
|
|
| 01/26/2021 |
4
| Hefti Franz (Chief Development Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 266,895 options to buy
@ $0.18, valued at
$48k
Disposed/sold 59,844 options to buy
@ $10.26, valued at
$614k
Disposed/sold 62,200 options to buy
@ $16.91, valued at
$1.1M
|
|
| 01/26/2021 |
4
| Kaplan Brett (CFO) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 347,004 options to buy
@ $0.18, valued at
$62.5k
Disposed/sold 64,565 options to buy
@ $10.26, valued at
$662.4k
Disposed/sold 95,000 options to buy
@ $16.91, valued at
$1.6M
|
|
| 01/26/2021 |
4
| Minkow Emily (Chief Business Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,000 shares
@ $0
Disposed/sold 149,000 options to buy
@ $0.18, valued at
$26.8k
Disposed/sold 104,895 options to buy
@ $0.18, valued at
$18.9k
Disposed/sold 108,854 options to buy
@ $10.26, valued at
$1.1M
Disposed/sold 54,000 options to buy
@ $16.91, valued at
$913.1k
|
|
| 01/26/2021 |
4
| Nader Francois (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 23,747 shares
@ $0
Disposed/sold 133,447 options to buy
@ $2.81, valued at
$375k
Disposed/sold 32,000 options to buy
@ $10.26, valued at
$328.3k
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| Schwartz Kira M. (General Counsel) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 100,000 options to buy
@ $16.68, valued at
$1.7M
|
|
| 01/26/2021 |
4
| Sevigny Jeffrey (Chief Medical Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 400,342 options to buy
@ $0.18, valued at
$72.1k
Disposed/sold 122,439 options to buy
@ $10.26, valued at
$1.3M
Disposed/sold 89,000 options to buy
@ $16.91, valued at
$1.5M
|
|
| 01/26/2021 |
4
| Sheng Morgan (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $10.62, valued at
$212.4k
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 1,576,881 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,822,463 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/26/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,822,463 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/22/2021 |
4
| Tyto Acquisition Corp (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Bought 34,284,789 shares
@ $22.5, valued at
$771.4M
|
|
| 12/31/2020 |
4
| Abeliovich Asa (President & CEO) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 89,037 shares
@ $23.02, valued at
$2M
Exercised 5,256 options to buy
@ $0.18, valued at
$946.1
Exercised 120,537 options to buy
@ $10.26, valued at
$1.2M
|
|
| 09/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 06/19/2020 |
4
| Sheng Morgan (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 06/19/2020 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 06/19/2020 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 06/19/2020 |
4
| Adams Timothy M (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 06/19/2020 |
4
| Nader Francois (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 06/03/2020 |
4
| Schwartz Kira M. (General Counsel) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 100,000 options to buy
@ $16.68, valued at
$1.7M
|
|
| 03/11/2020 |
4
| Dai Yong (Chief Technology Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 43,500 options to buy
@ $16.91, valued at
$735.6k
|
|
| 03/11/2020 |
4
| Hefti Franz (Chief Development Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 62,200 options to buy
@ $16.91, valued at
$1.1M
|
|
| 03/11/2020 |
4
| Minkow Emily (Chief Business Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 54,000 options to buy
@ $16.91, valued at
$913.1k
|
|
| 03/11/2020 |
4
| Kaplan Brett (CFO) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 95,000 options to buy
@ $16.91, valued at
$1.6M
|
|
| 03/11/2020 |
4
| Abeliovich Asa (President & CEO) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 250,000 options to buy
@ $16.91, valued at
$4.2M
|
|
| 03/11/2020 |
4
| Sevigny Jeffrey (Chief Medical Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 89,000 options to buy
@ $16.91, valued at
$1.5M
|
|
| 03/11/2020 |
4
| Minkow Emily (Chief Business Officer) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Exercised 13,000 options to buy
@ $0.18, valued at
$2.3k
|
|
| 11/18/2019 |
4
| Sheng Morgan (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.62, valued at
$212.4k
|
|
| 06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|